Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite toxoplasma gondii

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 6355-6369

  Anand, Namrata ^a   Sehgal, Rakesh ^a   Kanwar, Rupinder Kaur ^b   Dubey, Mohan Lal ^a   Vasishta, Rakesh Kumar ^a   Kanwar, Jagat Rakesh ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

Ceramic nanocapsules and reactive oxygen species; Cytokines; Immunoreactivity; Nanocapsules; Oral delivery; Parasite load; Toxoplasma gondii

Indexed keywords

CYTOKINE; LACTOFERRIN; MICRORNA; NANOCAPSULE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SULFADIAZINE; ALGINIC ACID; ANTIPROTOZOAL AGENT; CALCIUM PHOSPHATE; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG STABILITY; ENCAPSULATION; IN VITRO STUDY; IN VIVO STUDY; IRON METABOLISM; MACROPHAGE; MOUSE; MOUSE MODEL; NONHUMAN; PARASITE CLEARANCE; PARASITE LOAD; PARASITEMIA; SURVIVAL RATE; TISSUE DISTRIBUTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; BAGG ALBINO MOUSE; BOVINE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FEMALE; HUMAN; INTRACELLULAR SPACE; METABOLISM; ORAL DRUG ADMINISTRATION; PARASITOLOGY; PHYSIOLOGY; TOXOPLASMA;

ADMINISTRATION, ORAL; ALGINATES; ANIMALS; ANTIPROTOZOAL AGENTS; CALCIUM PHOSPHATES; CATTLE; CELL LINE; CHITOSAN; FEMALE; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; INTRACELLULAR SPACE; LACTOFERRIN; MACROPHAGES; MICE; MICE, INBRED BALB C; NANOCAPSULES; TOXOPLASMA;

EID: 84944077302     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S85286     Document Type: Article

References (34)

1. Gaddi PJ, Yap GS. Cytokine regulation of immunopathology in toxoplasmosis. Immunol Cell Biol. 2007;85(2):155–159.
2. Alcantara CS, Yang C-H, Steiner TS, et al. Interleukin-8, tumor necrosis factor-α, and lactoferrin in immunocompetent hosts with experimental and Brazilian children with acquired cryptosporidiosis. Am J Trop Med Hygiene. 2003;68(3):325–358.
3. Petersen E, Schmidt DR. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? 2003; Expert Rev Anti Infect Ther. 2003;1(1):175–182.
4. Baker EN, Baker HM. Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci. 2005;62(22):2531–2539.
5. Kanwar JR, Kanwar RK, Sun X, et al. Molecular and biotechnological advances in milk proteins in relation to human health. Curr Protein Pept Sci. 2009;10(4):308–338.
6. Kanyshkova TG, Buneva VN, Nevinsky GA. Lactoferrin and its biological functions. Biochemistry (Mosc). 2001;66(1):1–7.
7. López-Soto F, León-Sicairos N, Nazmi K, Bolscher JG, de la Garza M. Microbicidal effect of the lactoferrin peptides lactoferricin 17–30, lactoferrampin 265–284, and lactoferrin chimera on the parasite Entamoeba histolytica. Biometals. 2010;23(3):563–568.
8. Turchany JM, Aley SB, Gillin FD. Giardicidal activity of lactoferrin and N-terminal peptides. Infect Immun. 1995;63(11):4550–4552.
9. Ochoa TJ, Cleary TG. Effect of lactoferrin on enteric pathogens. Biochimie. 2009;91(1):30–34.
10. Tanaka T, Abe Y, Inoue N, et al. The detection of bovine lactoferrin binding protein on Trypanosoma brucei. J Vet Med Sci. 2004;66(6):619–625.
11. Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed Nanotechnol Biol Med. 2012;8(2):147–166.
12. Huang R, Ke W, Han L, et al. Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo. Brain Res Bull. 2010;81(6):600–604.
13. Kanwar JR, Mahidhara G, Kanwar RK. Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy. Nanomedicine. 2012;7(10):1521–1550.
14. Kanwar JR, Mahidhara G, Roy K, et al. Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc. Nanomedicine. 2015;10(1):35–55.
15. Kanwar JR, Palmano KP, Sun X, et al. ‘Iron-saturated’ lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy. Immunol Cell Biol. 2008;86(3):277–288.
16. Das RK, Kasoju N, Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomed Nanotechnol Biol Med. 2010;6(1):153–160.
17. Samarasinghe RM, Kanwar RK, Kanwar JR. The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis. Biomaterials. 2014;35(26):7522–7534.
18. Samarasinghe RM, Kanwar RK, Kumar K, Kanwar JR. Antiarthritic and chondroprotective activity of Lakshadi Guggul in novel alginate-enclosed chitosan calcium phosphate nanocarriers. Nanomedicine. 2014;9(6):819–837.
19. Bates GW, Wernicke J. The kinetics and mechanism of iron (III) exchange between chelates and transferrin IV. The reaction of transferrin with iron (III) nitrilotriacetate. J Biol Chem. 1971;246(11):3679–3685.
20. Feng M, van der Does L, Bantjes A. Preparation of apolactoferrin with a very low iron saturation. J Dairy Sci. 1995;78(11):2352–2537.
21. Young D, Hicks JM. Method for the automatic determination of serum iron. J Clin Pathol. 1965;18(1):98–102.
22. Amano F, Noda T. Improved detection of nitric oxide radical (NO) production in an activated macrophage culture with a radical scavenger, carboxy PTIO, and Griess reagent. FEBS Lett. 1995;368(3):425–458.
23. Pascoe S, Gatehouse D. The use of a simple haematoxylin and eosin staining procedure to demonstrate micronuclei within rodent bone marrow. Mutat Res. 1986;164(4):237–243.
24. Burg JL, Grover CM, Pouletty P, Boothroyd J. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 1989;27(8):1787–1792.
25. Singla B, Chakraborti A, Sharma BK, et al. Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients. Mol Biol Rep. 2014:1–8.
26. Anand N, Kanwar RK, Dubey ML, et al. Effect of Lactoferrin protein on RBCs and Macrophages: mechanism of parasite host interaction. Drug Design Devel Ther. 2015;9:3821–3835.
27. Kanwar JR, Roy K, Patel Y, et al. Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions. Molecules. 2015;20(6):9703–9731.
28. Ortíz-Estrada G, Luna-Castro S, Piña-Vázquez C, et al. Iron-saturated lactoferrin and pathogenic protozoa: could this protein be an iron source for their parasitic style of life? Future Microbiol. 2012;7(1):149–164.
29. Dziadek B, Brzostek A. Recombinant ROP2, ROP4, GRA4 and SAG1 antigen-cocktails as possible tools for immunoprophylaxis of toxoplasmosis: what’s next? Bioengineered. 2012;3(6):358–364.
30. Dziadek B, Dziadek J, Dlugonska H. Identification of Toxoplasma gondii proteins binding human lactoferrin: a new aspect of rhoptry proteins function. Exp Parasitol. 2007;115(3):277–282.
31. Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Dlugonska H. Toxoplasma gondii: The immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Exp Parasitol. 2009;123(1):81–89.
32. Omata Y, Satake M, Maeda R, et al. Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoites by treatment with bovine lactoferricin. J Vet Med Sci. 2001;63(2):187–190.
33. Gupta I, Sehgal R, Kanwar RK, Punj V, Kanwar JR. Nanocapsules loaded with iron-saturated bovine lactoferrin have antimicrobial therapeutic potential and maintain calcium, zinc and iron metabolism. Nanomedicine. 2014(0):1–26.
34. Baratchi S, Kanwar RK, Kanwar JR. Novel survivin mutant protects differentiated SK-N-SH human neuroblastoma cells from activated T-cell neurotoxicity. J Neuroimmunol. 2011;233(1):18–28.